Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapivirine vaginal ring and oral FTC/TDF in adolescent and young adult females
NCT03593655Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of dapivirine in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2019; status: completed.
02
Drugs
dapivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03593655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593655.